Head to head
Covista vs New Oriental
Side-by-side on the measures that matter, with a plain-English read. Full detail: CVSA · EDU
CVSA
Covista
109.13-5.52%
1-year price shape — +16% over the period
Quant Rating D · 58/100
vs
EDU
New Oriental
51.03-2.98%
1-year price shape — +0% over the period
Quant Rating D · 40/100
1-year performance, rebased to 100
New Oriental edges it on the scoreable measures. New Oriental pays the highest dividend yield.
| CVSA | EDU | |
|---|---|---|
| Snapshot | ||
| Sector | Education & Training Services | -- |
| Last price | 109.13 | 51.03 |
| Change today | -5.52% | -2.98% |
| 1-year return | +16.4% | +0.4% |
| Market cap | $3.63B | $7.90B |
| 52-week range | 86.97 – 142.13 | 43.42 – 63.02 |
| Valuation | ||
| P/E (TTM) | 14.91 | 15.95 |
| P/E percentile, own 5-yr range | 44th | 34th |
| P/B | 2.55 | 1.86 |
| Dividend yield | 0.00% | 2.35% |
| Profitability & growth | ||
| EPS (TTM) | 7.04 | 3.00 |
| Net profit (TTM) | $234.12M | $464.72M |
| Revenue (TTM) | $2.00B | $6.01B |
| Provider revenue period date | 2026-09-29 | 2026-08-30 |
| Revenue growth (YoY) | +10.7% | +23.1% |
| Gross margin | 57.4% | 54.3% |
| Operating margin | 20.1% | 11.8% |
| Net margin | 12.8% | 8.4% |
| Free cash flow (TTM) | $354.65M | $783.25M |
| Provider cash-flow period date | 2026-09-29 | 2026-08-30 |
| Ownership & sentiment | ||
| Institutional ownership | 112.4% | 67.3% |
| Insider activity (12mo) | 25 buy / 25 sell | 0 buy / 5 sell |
| Short interest (% of float) | 8.5% | 1.6% |
| Analyst consensus | 75% buy / 25% hold (4) | 100% buy (3) |
| Analyst price target | $159 (+46%) | $77 (+52%) |
| StockVane view | ||
| StockVane Quant Rating | D (58) | D (40) |
| Company | ||
| Employees | 10,680 | 88,372 |
| Founded | 1987 | 1993 |
▲ marks the more favourable stock(s) on measures with a clear direction (lower P/E, higher yield, higher Quant Rating, better 1-year return). Analyst consensus counts each covering institution once, at its most recent rating. Not a recommendation. Quant Rating method: Data & Methodology.